These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29805751)

  • 1. The cyclin-dependent kinase inhibitor flavopiridol (alvocidib) inhibits metastasis of human osteosarcoma cells.
    Zocchi L; Wu SC; Wu J; Hayama KL; Benavente CA
    Oncotarget; 2018 May; 9(34):23505-23518. PubMed ID: 29805751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibition and induction of apoptosis by flavopiridol in rat lung adenocarcinoma, osteosarcoma and malignant fibrous histiocytoma cell lines.
    Honoki K; Yoshitani K; Tsujiuchi T; Mori T; Tsutsumi M; Morishita T; Takakura Y; Mii Y
    Oncol Rep; 2004 May; 11(5):1025-30. PubMed ID: 15069542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin-dependent kinase inhibitor, flavopiridol, induces apoptosis and inhibits tumor growth in drug-resistant osteosarcoma and Ewing's family tumor cells.
    Li Y; Tanaka K; Li X; Okada T; Nakamura T; Takasaki M; Yamamoto S; Oda Y; Tsuneyoshi M; Iwamoto Y
    Int J Cancer; 2007 Sep; 121(6):1212-8. PubMed ID: 17520676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells.
    Raju U; Nakata E; Mason KA; Ang KK; Milas L
    Cancer Res; 2003 Jun; 63(12):3263-7. PubMed ID: 12810657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhabdoid tumor growth is inhibited by flavopiridol.
    Smith ME; Cimica V; Chinni S; Challagulla K; Mani S; Kalpana GV
    Clin Cancer Res; 2008 Jan; 14(2):523-32. PubMed ID: 18223228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
    Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R
    FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavopiridol-induced apoptosis during S phase requires E2F-1 and inhibition of cyclin A-dependent kinase activity.
    Jiang J; Matranga CB; Cai D; Latham VM; Zhang X; Lowell AM; Martelli F; Shapiro GI
    Cancer Res; 2003 Nov; 63(21):7410-22. PubMed ID: 14612540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alvocidib inhibits IRF4 expression via super-enhancer suppression and adult T-cell leukemia/lymphoma cell growth.
    Sakamoto H; Ando K; Imaizumi Y; Mishima H; Kinoshita A; Kobayashi Y; Kitanosono H; Kato T; Sawayama Y; Sato S; Hata T; Nakashima M; Yoshiura KI; Miyazaki Y
    Cancer Sci; 2022 Dec; 113(12):4092-4103. PubMed ID: 36047964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavopiridol enhances the effect of docetaxel in vitro and in vivo in human gastric cancer cells.
    Motwani M; Rizzo C; Sirotnak F; She Y; Schwartz GK
    Mol Cancer Ther; 2003 Jun; 2(6):549-55. PubMed ID: 12813134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical and clinical development of the cyclin-dependent kinase inhibitor flavopiridol.
    Shapiro GI
    Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4270s-4275s. PubMed ID: 15217973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyr61 expression in osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice.
    Sabile AA; Arlt MJ; Muff R; Bode B; Langsam B; Bertz J; Jentzsch T; Puskas GJ; Born W; Fuchs B
    J Bone Miner Res; 2012 Jan; 27(1):58-67. PubMed ID: 21976359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flavopiridol and trastuzumab synergistically inhibit proliferation of breast cancer cells: association with selective cooperative inhibition of cyclin D1-dependent kinase and Akt signaling pathways.
    Wu K; Wang C; D'Amico M; Lee RJ; Albanese C; Pestell RG; Mani S
    Mol Cancer Ther; 2002 Jul; 1(9):695-706. PubMed ID: 12479366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flavopiridol induces cell cycle arrest and p53-independent apoptosis in non-small cell lung cancer cell lines.
    Shapiro GI; Koestner DA; Matranga CB; Rollins BJ
    Clin Cancer Res; 1999 Oct; 5(10):2925-38. PubMed ID: 10537362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and repressing u-PA/MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and reduces 143B tumor growth in vivo.
    Lu KH; Chen PN; Hsieh YH; Lin CY; Cheng FY; Chiu PC; Chu SC; Hsieh YS
    Food Chem Toxicol; 2016 Nov; 97():177-186. PubMed ID: 27600294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung cells support osteosarcoma cell migration and survival.
    Yu S; Fourman MS; Mahjoub A; Mandell JB; Crasto JA; Greco NG; Weiss KR
    BMC Cancer; 2017 Jan; 17(1):78. PubMed ID: 28122543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent inhibition of rhabdoid tumor cells by combination of flavopiridol and 4OH-tamoxifen.
    Cimica V; Smith ME; Zhang Z; Mathur D; Mani S; Kalpana GV
    BMC Cancer; 2010 Nov; 10():634. PubMed ID: 21092078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GREM1 overexpression inhibits proliferation, migration and angiogenesis of osteosarcoma.
    Gu Q; Luo Y; Chen C; Jiang D; Huang Q; Wang X
    Exp Cell Res; 2019 Nov; 384(1):111619. PubMed ID: 31525341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical activity of alvocidib (flavopiridol) in acute myeloid leukemia.
    Zeidner JF; Karp JE
    Leuk Res; 2015 Dec; 39(12):1312-8. PubMed ID: 26521988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flavopiridol's effects on metastasis in KRAS mutant lung adenocarcinoma cells.
    Dogan Turacli I; Demirtas Korkmaz F; Candar T; Ekmekci A
    J Cell Biochem; 2019 Apr; 120(4):5628-5635. PubMed ID: 30317654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53.
    Byrd JC; Shinn C; Waselenko JK; Fuchs EJ; Lehman TA; Nguyen PL; Flinn IW; Diehl LF; Sausville E; Grever MR
    Blood; 1998 Nov; 92(10):3804-16. PubMed ID: 9808574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.